Titanium ( DrugBank: Titanium )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 69 | 後縦靱帯骨化症 | 1 |
| 70 | 広範脊柱管狭窄症 | 3 |
69. 後縦靱帯骨化症
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 3) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR1800020231 | 2017-12-01 | 2018-12-20 | Single-center comparison for the efficacy and safety of posterior cervical single-door open laminoplasty with mini-titanium plate fixation and posterior cervical double-door open laminoplasty with lateral mass screw fixation and fusion in the treatment of Ossification of Posterior Longitudinal Ligament ( OPLL ) | Single-center comparison for the efficacy and safety of posterior cervical single-door open laminoplasty with mini-titanium plate fixation and posterior cervical double-door open laminoplasty with lateral mass screw fixation and fusion in the treatment of Ossification of Posterior Longitudinal Ligament ( OPLL ) | Ossification of Posterior Longitudinal Ligament ( OPLL ) | A:Posterior cervical single-door open laminoplasty with mini-titanium plate fixation;B:Posterior cervical double-door open laminoplasty with lateral mass screw fixation and fusion; | Shandong provincial hospital affiliated to Shandong university | NULL | Recruiting | 18 | 65 | Both | A:31;B:31; | China |
70. 広範脊柱管狭窄症
臨床試験数 : 96 / 薬物数 : 203 - (DrugBank : 60) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 89
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05023733 (ClinicalTrials.gov) | October 1, 2021 | 16/8/2021 | Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular Implant | Clinical and Radiographic Outcomes of Transforaminal Lumbar Interbody Fusion (TLIF) With a Novel 3D Printed Cellular Titanium Implant | Foraminal Stenosis;Degenerative Disc Disease;Lumbar Spondylolisthesis;Lumbar Spinal Stenosis | Device: CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium® | Farhan Karim | DePuy Synthes | Not yet recruiting | 35 Years | 80 Years | All | 150 | United States | |
| 2 | NCT03647501 (ClinicalTrials.gov) | August 22, 2018 | 21/8/2018 | Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody Cages | Lumbar Fusion With 3D-Printed Porous Titanium Interbody Cages - A Single-Blinded Randomized Controlled Trial Evaluating Nexxt Matrixx(TM) Versus PEEK Cages | Lumbar Degenerative Disc Disease;Lumbar Spinal Stenosis;Lumbar Spondylolisthesis;Lumbar Spinal Deformity;Lumbar Spondylosis | Device: Interbody cage (titanium);Device: Interbody cage (PEEK) | Ohio State University | Nexxt Spine, LLC | Recruiting | 18 Years | N/A | All | 70 | N/A | United States |
| 3 | NCT03532945 (ClinicalTrials.gov) | October 28, 2010 | 2/5/2018 | A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody Fusion | A Long-term Follow-up Study to Evaluate the Efficacy and Safety for the Patients With Bioactive Glass-ceramic Intervertebral Spacer (Novomax) in Posterior Lumbar Interbody Fusion: Comparison With a Titanium Cage | Degenerative Lumbar Spinal Stenosis | Device: Bioactive Glass-Ceramic Spacer;Device: Titanium cage | BioAlpha Inc. | NULL | Completed | 30 Years | 80 Years | All | 62 | N/A | NULL |